by European Public Health Alliance | Oct 3, 2022 | #A2Medicines, COVID-19
It is undeniable that COVID-19 put a lot of pressure on the entire international health system, bringing the workload and intensity of care professionals to the extreme. Although the situation improved a lot over the last months, we cannot let our guard down and we...
by European Public Health Alliance | Sep 23, 2022 | #A2Medicines, #VaccineEquity, COVID-19, Health Inequalities
In September 2022, the European Public Health Association published a joint statement co-signed by several health NGOs, including EPHA. The purpose of this letter is to address the health emergency preparedness, learn from the pandemic, and improve the general...
by European Public Health Alliance | Apr 20, 2022 | Antimicrobial Resistance | Analysis & Opinion, COVID-19, Digital Health | Analysis & Opinion, Healthy Economic Policy | Analysis & Opinion, Non Communicable Diseases (NCDs), Universal Access and Affordable Medicines | Analysis & Opinion
The European Parliament is undertaking an extremely important task of examining how the European Union has dealt with the response to the ongoing COVID-19 pandemic. We know that its impact on almost every aspect of our lives and livelihoods has been and often...
by European Public Health Alliance | Feb 25, 2022 | COVID-19, The View from EPHA, Universal Access and Affordable Medicines | Analysis & Opinion
Guest article by Tamsin Rose, Senior Fellow for Health at Friends of Europe and former Secretary-General at EPHA COVID-19 was unprecedented but not unpredicted. In 2018, the WHO designated ‘Disease X‘ as representing the knowledge that a serious international epidemic...
by European Public Health Alliance | Feb 25, 2022 | COVID-19, EPHA News, The View from EPHA
As I write, I am conscious that we are approaching the two-year anniversary of COVID-19’s arrival in Europe. My last in-person meeting was an EPHA Board meeting in early March 2020, and I recall us all wondering around the table quite what the future would hold.In...
by European Public Health Alliance | Feb 25, 2022 | #VaccineEquity, COVID-19
Marije Versteeg, Senior Global Health Advocate at Wemos, @Marije_Versteeg Since the onset of the pandemic, a multitude of access initiatives and proposals have been initiated by public and multilateral institutions worldwide, ranging from COVAX, the...
